Developer of screening technologies intended to reduce the incidence of cancer. The company's technologies are based on ultra-deep gene sequencing technology, bioinformatics analysis and big data analysis which helps in detecting cancer in precancerous lesions or at the early-stage, providing patients with increased chances of survival and reduced mortality rates.